Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof
CA 2036814 C · Owner: Peters, Helmut · Inventors: Peters, Helmut; Boblet, Klaus; Auerbach, Bernhard
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to monoclonal antibodies (MAbs) and fragments thereof which bind to defined tumor-associated antigens, principally of small cell lung carcinoma (SCLC), of melanoma, of neuroblastoma and other tumors of neuroectodermal origin, to hybridoma cell lines for the preparation thereof, and to the antigens which can be defined and/or isolated with the aid of these antibodies or antibody fragments. The antibodies anti-, body fragments and antigens can be used as diagnostic aid, active substance or active substance carrier.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 21, 1991 and granted June 25, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 21, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 21, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.